Stay updated on Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A note explains that PubMed publications shown are auto-filled and may not pertain to the study. Revision: v3.3.2 is now listed.
    Difference
    0.1%
    Check dated 2025-11-25T13:51:21.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The funding-status notice about potential data updates due to government funding lapses is removed, along with the associated operating-status guidance. The page no longer displays the disclaimer and the link to opm.gov for updates.
    Difference
    0.3%
    Check dated 2025-11-18T07:21:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study record shows updated last update dates (e.g., Last Update Posted 2025-05-07) with no changes to the trial design or eligibility.
    Difference
    0.4%
    Check dated 2025-11-03T21:22:38.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:51:27.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:43.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:58:12.000Z thumbnail image

Stay in the know with updates to Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Brentuximab Post-SCT in Hodgkin Lymphoma Clinical Trial page.